ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2023

Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light.

Mark Hj Wessels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.